What Is a Ductectomy? Types, Recovery, and Alternatives

Ductectomy is the surgical removal of one or more milk ducts from the breast, performed most often to diagnose or treat pathological nipple discharge. The procedure comes in two main forms: removal of a single offending duct (commonly called microdochectomy or selective ductectomy) and removal of the entire central duct system (total duct excision, sometimes called a Hadfield’s procedure). While nipple discharge has many harmless causes, ductectomy remains the standard method for ruling out an underlying malignancy when imaging alone cannot provide a clear answer, and the choice between the two approaches carries real consequences for sensation, breastfeeding potential, and recurrence risk.

Why Ductectomy Is Performed

The primary reason surgeons recommend ductectomy is pathological nipple discharge, meaning discharge that is spontaneous, comes from a single duct opening, and is often bloody or clear. This type of discharge differs from the milky, multi-duct secretion that can happen during hormonal changes and is usually harmless. Physiologic discharge typically requires nothing beyond routine screening mammography, whereas pathological discharge triggers a more involved workup because it can signal an intraductal papilloma, atypical cells, or cancer.¹

Central duct excision has long been considered the standard approach when a malignancy needs to be excluded in someone with pathological nipple discharge. Studies suggest, however, that when breast MRI shows no suspicious findings, surveillance alone may be a reasonable alternative to surgery, given MRI’s high ability to rule out cancer.² That evolving thinking has not eliminated the need for ductectomy, but it has narrowed the group of patients who truly need to go to the operating room.

Imaging and Testing Before Surgery

Before any duct excision, the standard first step is mammography combined with ultrasound. When those are inconclusive, additional tools come into play. Galactography (also called ductography) involves injecting contrast dye into the discharging duct and then taking X-ray images. It has traditionally been the primary method for visualizing intraductal lesions, and it is especially useful for detecting malignant causes that might appear only as subtle duct widening on ultrasound.³ That said, galactography is not as accurate as you might expect: one ten-year study found its sensitivity was about 63% and its specificity was only around 36%.⁴

MRI tends to be better at ruling out malignancy than galactography. One study evaluating patients with pathological nipple discharge without intraductal imaging found that MRI had a specificity of about 88%, meaning it was good at correctly identifying people who did not have a worrisome lesion, though its sensitivity for detecting intraductal lesions was lower at roughly 43%.⁵ That high specificity is what makes MRI attractive as a gatekeeper: if MRI looks clean, some clinicians are comfortable offering close surveillance instead of surgery.

Cytology of the nipple discharge fluid is another preoperative tool, though it has real limitations. Standard smear cytology diagnoses intraductal papillomas correctly only about 41% of the time and catches malignant intraductal tumors just 23% of the time. A newer approach, liquid-based cytology from ductal lavage fluid, performs substantially better, with accuracy rates around 59% for papillomas and 68% for malignant tumors.⁶ Neither version is reliable enough on its own to substitute for tissue sampling, but improved cytology can help prioritize which patients need surgery most urgently.

Microdochectomy vs. Total Duct Excision

The choice between these two operations is one of the most consequential decisions in ductectomy, and it depends on how many ducts appear to be involved, the patient’s age and reproductive plans, and how much tissue needs to come out for a reliable diagnosis.

Microdochectomy (sometimes spelled microductectomy) targets a single discharging duct. A fine probe or guide wire is threaded into the affected duct through the nipple opening, and the surgeon follows that guide to remove just the duct and a small margin of surrounding tissue.⁷ Because it removes only one duct, this technique preserves the rest of the ductal system and the blood supply to the nipple. For premenopausal people who may want to breastfeed in the future, microdochectomy is generally the preferred option when clinical presentation supports single-duct involvement.⁸

Total duct excision (TDE), by contrast, removes the entire central duct system beneath the nipple. The classic version, Hadfield’s procedure, uses a periareolar incision. The nipple is lifted off the underlying breast tissue, and a cone-shaped block of tissue containing all the major ducts is excised. Volume displacement with tissue flaps helps prevent the nipple from inverting afterward.⁹ TDE provides a larger tissue specimen, which may increase the chance of catching a small malignancy, but it comes with a heftier complication profile. The original description of the procedure noted loss of nipple sensation in many patients, nipple retraction in about 10%, and occasional full necrosis of the nipple-areola complex.¹⁰ TDE also eliminates the possibility of breastfeeding on that side, which makes it a more definitive but less reversible choice.

What Ductectomy Specimens Reveal Under the Microscope

For many patients, the value of ductectomy is as much diagnostic as it is therapeutic. The most common finding by far is an intraductal papilloma, a small benign growth inside the duct that is almost always the source of the bleeding. In one large ductoscopy study of 247 patients, about three-quarters had an intraductal tumor, the vast majority of which were papillomas. Among those patients, roughly 4% turned out to have a malignant tumor: about 1.6% were ductal carcinoma in situ (DCIS, an early non-invasive form) and about 2.4% were invasive ductal carcinoma.¹¹

A more recent microdochectomy series found a higher malignancy rate. In 115 cases, DCIS was found in about 6% of specimens, and invasive breast cancer accompanied the DCIS in roughly a quarter of those, yielding a malignant upgrade rate of about 6%.¹² In a separate TDE series of 259 cases with a median follow-up of 45 months, about 3.5% of patients were ultimately diagnosed with DCIS or invasive cancer.¹³ The variability across studies reflects differences in patient selection and imaging practices, but the overall message is consistent: the great majority of ductectomy specimens are benign, yet a meaningful minority harbor cancer that preoperative imaging missed.

The Role of Ductoscopy

Mammary ductoscopy uses a tiny fiber-optic camera inserted directly into the duct opening at the nipple. The surgeon can see the lining of the duct in real time, identify lesions deep within the ductal tree, and guide a more targeted excision. This matters because lesions far from the nipple can be missed by a conventional blind duct excision, where the surgeon removes a cone of tissue and hopes it contains the culprit.¹⁴

One comparison found that ductoscopy-guided excision caught atypical hyperplasia or DCIS in about 19% of specimens, compared with about 9% in conventional total duct excision.¹⁵ That roughly doubled pick-up rate for significant pathology is striking, and it likely reflects the ability to see and target abnormal areas rather than sampling tissue blindly.

Ductoscopy is also increasingly used as an alternative to surgery altogether. In single-center experience, interventional ductoscopy safely replaced major duct excision or microdochectomy in the diagnostic workup for pathological nipple discharge, sparing some patients an operation entirely.¹⁶ One helpful technique that pairs with ductoscopy is the immediate injection of methylene blue dye after the scope is removed. The dye stains the discharging duct and the lesion inside it, making it far easier for the surgeon to identify the right tissue during selective ductectomy without spillover into surrounding ducts.¹⁷

Recurrence After Ductectomy

Discharge coming back after ductectomy is not rare. In one TDE series, nipple discharge recurred in about 14% of cases overall. For patients who had already undergone a previous TDE and required a repeat procedure, the recurrence rate climbed to about 31%.¹⁸ A systematic review covering multiple studies found recurrence rates of pathological nipple discharge ranging from 0% to 12%, and breast cancer developed during follow-up in fewer than 1% of patients across the pooled data.¹⁹

Recurrence does not necessarily mean something sinister. The most common explanation is that the original excision did not capture the full extent of duct pathology, or that new papillomas developed in a different duct. Still, any recurrent discharge warrants a fresh evaluation, including imaging and possibly re-excision, because the small residual risk of malignancy does not disappear just because the first surgery was benign.

Vacuum-Assisted Excision as a Less Invasive Alternative

Not every intraductal papilloma needs an open operation. Vacuum-assisted excision (VAE) uses a specialized probe inserted through a small skin incision, guided by ultrasound or stereotactic imaging, to suction out the lesion piece by piece. It preserves the breast’s ductal structure, leaves minimal scarring, and can be done as an outpatient procedure with a shorter recovery than traditional surgery.²⁰

A comparison of two percutaneous techniques, VAE and the breast lesion excision system (BLES), found that both were effective for treating intraductal papillomas. In most cases where the lesion was non-malignant, open surgery was avoided entirely, though VAE handled larger lesions more easily than BLES.²¹ In a small early series, four women with benign papillomas and no atypia had their nipple discharge stop completely after VAE, suggesting the procedure was both diagnostic and therapeutic.²²

The catch is that VAE is most reliable when imaging has already pinpointed a visible lesion. If ultrasound shows no clear target, the probe has nothing to aim at, and a ductectomy may still be needed to obtain a definitive tissue diagnosis. VAE also provides less tissue than formal excision, which can sometimes make it harder for the pathologist to fully characterize borderline lesions. For confirmed benign papillomas, though, it is an attractive way to solve the problem without a trip to the operating room.

Complications and What to Expect

The specific complications of ductectomy depend heavily on whether the procedure is a microdochectomy or a total duct excision. Microdochectomy is generally a smaller operation with fewer consequences. Wound infection, minor bleeding, and temporary numbness around the nipple are the main short-term risks. Because only one duct is removed, nipple appearance and sensation are usually well preserved.

Total duct excision carries a more significant risk profile. As mentioned earlier, Hadfield’s original technique was associated with nipple retraction in about 10% of patients and loss of sensation in many cases.²³ Modern modifications, including different incision patterns and tissue rearrangement with glandular flaps, have been developed specifically to reduce these problems.²⁴ But TDE remains the more disruptive surgery, and anyone considering it should understand that some degree of nipple numbness is common and that cosmetic changes, while usually manageable, are possible.

Both procedures are typically performed as day surgery under general or local anesthesia with sedation. Most people return to light activity within a few days and fully resume normal routines within a couple of weeks, depending on the extent of the excision.

Breastfeeding After Ductectomy

Whether you can breastfeed after ductectomy depends entirely on which type was performed and which breast was involved. After microdochectomy, the remaining ducts are intact and functional. Some reduction in milk output on that side is possible if surrounding tissue was disrupted, but breastfeeding is generally still feasible. This is a key reason microdochectomy is preferred for premenopausal individuals who may want to nurse in the future.²⁵

After total duct excision, breastfeeding from the operated breast is no longer possible because there are no remaining ducts to carry milk to the nipple. Breastfeeding from the other breast is unaffected, and many people nurse successfully from one side alone, though milk supply is typically lower than with two functioning breasts. If future breastfeeding is important to you, make sure your surgeon knows before the procedure is scheduled.

Ductectomy in Men

Nipple discharge in men is uncommon and tends to raise more alarm than the same symptom in women, because male breast tissue is much less extensive and the differential diagnosis is narrower. In one large TDE series of 259 cases, two were performed in male patients.²⁶ The surgical technique is essentially the same. The rarity of male cases means there is little dedicated research, but the general principle holds: when pathological nipple discharge cannot be explained by imaging, duct excision provides the most definitive way to rule out malignancy.

When Surgery May Not Be Necessary

The trend in breast surgery over the past two decades has been to do less when less is safe. For ductectomy specifically, several developments are steering selected patients away from the operating room. MRI with its high specificity allows some clinicians to recommend close surveillance instead of surgery when imaging is completely negative. Interventional ductoscopy can diagnose and sometimes treat intraductal lesions without open excision.²⁷ And vacuum-assisted excision handles many confirmed papillomas percutaneously, without a formal operation.²⁸

None of these alternatives entirely replaces ductectomy. When discharge is bloody, when imaging shows a suspicious finding, or when preoperative biopsies reveal atypical cells, surgery still provides the most reliable tissue diagnosis. The decision often comes down to a conversation about individual risk: age, family history, how worrisome the imaging looks, and how comfortable both patient and surgeon are with watching rather than cutting. The threshold for surgery is lower in older patients, who are more likely to harbor malignancy and less likely to need their ducts for lactation, and higher in younger patients with a single clear duct and reassuring imaging.

What has changed is that ductectomy is no longer the automatic next step for every case of pathological nipple discharge. The preoperative workup has become sophisticated enough to stratify risk, and minimally invasive techniques have expanded the menu of options. For the patients who do proceed to surgery, the operation is straightforward, recovery is quick, and the information gained from the tissue specimen remains unmatched by any imaging modality available today.